Global top 5 companies by forecasted oncology sales 2030
The top five pharmaceutical companies based on projected global oncology revenue in 2030 include Johnson & Johnson, AstraZeneca, and Roche, to name a few. Roche’s oncology products are expected to generate some 24 billion U.S. dollars in that year.
Oncology pharmaceuticals
Among U.S. oncology brands in 2023, Merck’s Keytruda was the top revenue generating oncology brand. Also, globally, Keytruda was the top oncology product in 2023. There are many new cancer drugs in development. Drugs against cancer are by far the largest therapeutic group of products in the R&D pipeline worldwide.
Cancer prevalence and treatments
The U.S. and leading EU countries had the highest prevalence of diagnosed cancer cases globally as of 2019. Among all types of cancer, trachea, bronchus and lung cancer are the deadliest, followed by liver cancer. The availability of cancer treatments varies around the world. The U.S. and Germany had the largest number of new medications for cancer available.
